Reports Q3 revenue $927.9M, consensus $915.84M. “The Donaldson team delivered outstanding performance in the third quarter, generating record sales and earnings with robust margins, while continuing to set a stronger foundation for future profitable growth through ongoing strategic investments,” said Tod Carpenter, chairman, president and chief executive officer. “Despite mixed end-market conditions, we maintained focus on our customers and delivered our technology-led filtration products and services across our diversified portfolio of businesses.” “Driven by third quarter results and our expectations for strong performance in the fourth quarter, we are increasing our earnings outlook for the full year. Looking ahead, we remain committed to returning value to our shareholders through the execution of our longer-term strategic initiatives and continued progress towards our fiscal 2026 Investor Day targets.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCI:
- DCI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Donaldson raises quarterly cash dividend 8% to 27c per share
- Donaldson, PolyPeptide to partner in peptide purification
- Donaldson to acquire 49% stake in Medica, terms undisclosed
- Donaldson price target raised to $62 from $59 at Morgan Stanley